Merck and Ridgeback Report Results for Lagevrio in P-II Studies for the Treatment of COVID-19
October 7, 2022
Yoshio Okubo, Senior Director, Head of Pandemic Global Product Team for Takeda Shares Insights on the Approval of its Covid-19 Vac...
October 4, 2022
Pfizer and BioNTech Report EUA Submission to the US FDA for Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children Aged 5-...
September 26, 2022
Dr. Changjin Wang, CEO at Frontier Biotechnologies, Shares Insights on P-I Results of its Coronavirus Mpro Inhibitor
September 19, 2022
Gilead’s Veklury (remdesivir) Receives WHO’s Recommendation for the Treatment of COVID-19
September 16, 2022
Valeo Pharma Enters into a Commercial Services Agreement with Veru for Sabizabulin to Treat COVID-19 in Canada
September 14, 2022
No more records!
Incisive News in 3 Shots.
First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2022 PharmaShots - All Rights Reserved.